About 7,193 results

ALLMedicine™ Pleural Effusion Center

Research & Reviews  2,616 results

Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients...
Cancer Research and Treatment; Kim YJ, Ji WJ et. al.

Jan 19th, 2022 - This study was to evaluate anti-tumor efficacy of osimertinib in patients positive for acquired epidermal growth factor receptor (EGFR) T790M mutation in liquid biopsy using plasma, bronchoalveolar lavage fluid (BALF) or bronchial washing fluid (B...

A 58-Year-Old Woman with Gallstones, Chronic Pancreatitis, and Pancreatic Pseudocyst Pr...
The American Journal of Case Reports; Jamil SB, Abbas SH et. al.

Jan 15th, 2022 - BACKGROUND Pancreaticopleural fistula (PPF) is a rare complication of acute and chronic pancreatitis. PPF results from the release of pancreatic enzymes, either from a damaged pancreatic duct or pancreatic pseudocyst. This report is of a 58-year-o...

Diagnostic method for malignant pleural effusion distinguishing malignant mesothelioma ...
Medicine Saraya T, Ohkuma K et. al.

Jan 15th, 2022 - Malignant mesothelioma (MM) is difficult to diagnose because of the lack of parenchymal opacities, often revealing minimal or absent pleural thickening. Furthermore, pleural effusion has diverse differential diagnoses, including malignancies, infe...

Pleural Metastasis of Papillary Thyroid Cancer Depicted by 68Ga-FAPI PET/CT.
Clinical Nuclear Medicine; Chen Y, Zheng S et. al.

Jan 14th, 2022 - A 43-year-old woman with history of papillary thyroid cancer status post total thyroidectomy and neck dissection and multiple radioiodine therapy developed dyspnea and cough. CT scan of the chest showed left pleural thickening and pleural effusion...

A prediction rule for severe adverse events in all inpatients with community-acquired p...
BMC Pulmonary Medicine; Sakakibara T, Shindo Y et. al.

Jan 14th, 2022 - Prediction of inpatients with community-acquired pneumonia (CAP) at high risk for severe adverse events (SAEs) requiring higher-intensity treatment is critical. However, evidence regarding prediction rules applicable to all patients with CAP inclu...

see more →

Guidelines  2 results

Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emer...
Annals of Internal Medicine; Qaseem A, Etxeandia-Ikobaltzeta I et. al.

Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings...

ACR Appropriateness Criteria® Pneumonia in the Immunocompetent Child.
Journal of the American College of Radiology : JACR; , Chan SS et. al.

May 7th, 2020 - Pneumonia is one of the most common acute infections and the single greatest infectious cause of death in children worldwide. In uncomplicated, community-acquired pneumonia in immunocompetent patients, the diagnosis is clinical and imaging has no ...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  91 results

Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors

Dec 23rd, 2021 - Background: -Malignant ascites or pleural effusions are often seen in patients with solid tumor malignancies. -Malignant ascites is proinflammatory with many cytokines present and acts to promote tumor cell growth. -The cellular composition of mal...

Pleural Manometry for the Characterization of Spontaneous and Tension Pneumothorax

Dec 10th, 2021 - The rate of hospitalization for spontaneous pneumothorax among people age 14 or older is approximately 227 per million. Spontaneous pneumothorax in the absence of trauma can be further classified as primary spontaneous pneumothorax (PSP) or second...

Bedside Lung Ultrasonography by Nurses in Acute Dyspnea.

Nov 19th, 2021 - Dyspnea is one of the most distressing situations for the patient . Emergency cases do not always present in conditions that are ideal for immediate diagnosis, which sometimes compromises outcome. Physical examination, laboratory findings and radi...

Dasatinib Holiday for Improved Tolerability

Oct 6th, 2021 - Dasatinib is indicated in Europe for: Treatment of adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase Chronic, accelerated or blast phase CML with resistance or intoleranc...

Diagnosis and Classification of Pleural Diseases Using Ultrasound Channel Data

Sep 20th, 2021 - Background and rationale: The Pleura is a double-layered membrane surrounding the lungs. It is anatomically divided into Visceral Pleura, which is attached to the outer part of the lungs, and to the Parietal Pleura, which is attached to the inner ...

see more →

News  157 results

Zanidatamab/Chemo Showcases Early Safety, Antitumor Activity in HER2+ Breast Cancer

Jan 4th, 2022 - The addition of the bispecific antibody zanidatamab to single-agent chemotherapy was found to produce promising antitumor activity with acceptable tolerability in heavily pretreated patients with HER2-positive breast cancer, according to data from...

Dr. Krug on Intra-Pleural Administration of GL-ONC1 in Patients With Malignant Pleural Effusion

Oct 6th, 2021 - Lee M. Krug, MD, associate attending physician, Division of Thoracic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, discusses a phase I study examining intra-pleural administration of GL-ONC1 in patients with malignant p...

Active Engagement of Pulmonology Is a Must in the Multidisciplinary Management of Lung Cancer

Sep 9th, 2021 - Pulmonologists play a critical role in the diagnosis and staging of lung cancer, the latter of which should always include thorough lymph node evaluation with endobronchial ultrasound before a patient is presented to a multidisciplinary tumor boar...

Negative Trials Close the Book on Once-Promising SCLC Drug

Sep 7th, 2021 - A once-hopeful antibody-drug conjugate for small cell lung cancer (SCLC) failed to demonstrate a survival benefit in two large randomized studies, and was mostly too toxic. In the phase III MERU trial, patients with extensive-stage SCLC who receiv...

Therapeutic drug monitoring based on dasatinib dose optimization reduces PIEff incidence in CML

Jul 30th, 2021 - Key clinical point: Dasatinib dose optimization by therapeutic drug monitoring (TDM) during treatment initiation in patients with newly diagnosed chronic myeloid leukemia (CML) was feasible and led to a significant reduction in pleural effusion (P.

see more →

Patient Education  4 results see all →